Physicians' Academy for Cardiovascular Education

Stratifying stroke risk to guide antithrombotic therapy in patients with AF

Slides (presentation) - Dec. 27, 2012

Slide lecture program (12 slides): View & Download

  1. No evidence that AF type significantly impacts stroke risk
  2. Stroke Risk in AF Working Group: factors influencing stroke risk in patients with AF
  3. Different schemes designed to stratify stroke risk in patients with AF
  4. Differences in risk stratification schemes yield varying degrees of stroke risk
  5. CHADS2 is the most recognized risk stratification scheme
  6. ACCF/AHA/HRS 2011 and ACCP 2008 guidelines: based on CHADS2
  7. CHA2DS2-VASc: a further refinement of CHADS2
  8. ESC 2010 guidelines: based on CHADS2 and CHA2DS2-VASc
  9. Many stroke risk factors are also risk factors for bleeding
  10. 1-year risk of major bleeding increases with HAS-BLED score
  11. ATRIA: a risk scheme to predict warfarin-associated haemorrhage
Stratifying stroke risk to guide antithrombotic therapy
No evidence that AF type significantly impacts stroke risk
Stroke Risk in AF Working Group
Different schemes designed to stratify stroke risk
Differences in risk stratification schemes
CHADS2 is the most recognized risk stratification scheme
ACCF/AHA/HRS 2011 and ACCP 2008 guidelines
CHA2DS2-VASc: a further refinement of CHADS2
ESC 2010 guidelines: based on CHADS2 and CHA2DS2-VASc
Many stroke risk factors are also risk factors for bleeding
1-year risk of major bleeding increases with HAS-BLED score
ATRIA: a risk scheme to predict warfarin-associated haemorrhage

Share this page with your colleagues and friends: